You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 07/21/2014

Company Name Symbol %Change
HI CRUSH PAR HCLP
4.74%
CURIS INC CRIS
4.19%
CENTRAL VALL CVCY
3.94%
MIDSTATES PE MPO
3.44%
CTPARTNERS E CTP
3.12%

Tale of the Tape

Gentiva (GTIV) Worth Watching: Stock Gains 16.1%

Posted Mon Jul 21, 09:46 am ET

by Zacks Equity Research

Gentiva Health Services Inc. (GTIV) was a big mover last session with its shares rising over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month’s volatile price range of $15.02 to $16.21.

This provider of home health, hospice, and community care services has witnessed one positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s rally can turn into more strength down the road.

Gentiva currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.

Investors interested in the home health care industry may also consider stocks like AmSurg Corp. (AMSG), Amedisys Inc. (AMED) and RadNet, Inc. (RDNT). All the three stocks hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session

Posted Mon Jul 21, 09:39 am ET

by Zacks Equity Research

AcelRx Pharmaceuticals, Inc. (ACRX) was a big mover last session, as its shares rose nearly 12% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Jul 3, as the stock is now down over 12%.

In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate moved slightly higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

AcelRx Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the med-drugs industry include Enanta Pharmaceuticals, Inc. (ENTA), Endo International plc (ENDP) and Ironwood Pharmaceuticals, Inc. (IRWD). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Premiere Global Services (PGI) Jumps: Stock Rises 7.2%

Posted Mon Jul 21, 09:32 am ET

by Zacks Equity Research

Premiere Global Services, Inc. (PGI) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $12.80 to $13.59 over the past one month time frame.

None of the estimates for this communications components industry stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Premiere Global Services carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

However, some better-ranked stocks in the same industry include Corning Inc. (GLW), Vocera Communications, Inc. (VCRA) and KVH Industries Inc. (KVHI). While Corning and Vocera Communications sport a Zacks Rank #1 (Strong Buy), KVH Industries holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Zacks Rank #5 Additions for Monday

Posted Mon Jul 21, 09:30 am ET

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • AMAG Pharmaceuticals, Inc. ( AMAG )
  • American Vanguard Corp. ( AVD )
  • Boardwalk Pipeline Partners, LP (BWP )
  • Compania de Minas Buenaventura SAA (BVN)
  • Cliffs Natural Resources Inc (CLF)

View the entire Zacks Rank #5 List.

 

Zacks Rank #1 Additions for Monday

Posted Mon Jul 21, 09:30 am ET

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

  • Aetna Inc (AET)
  • Allegiant Travel Company (ALGT)
  • Baker Hughes Incorporated (BHI)
  • Berkshire Hathaway Inc. (BRK.A)
  • H & R Block Inc (HRB)

View the entire Zacks Rank #1 List.

 

Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher

Posted Mon Jul 21, 09:25 am ET

by Zacks Equity Research

Ultragenyx Pharmaceutical Inc. (RARE) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company, as the stock has lost nearly 15% since July 3.

This biotechnology company has seen no estimate revision in the last 7 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s rally can turn into more strength down the road.

Ultragenyx currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Investors interested in the biomedical industry may consider better-ranked stocks like Curis, Inc. (CRIS), Biogen Idec Inc. (BIIB) and Actelion Ltd. (ALIOF). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Noranda Aluminum Holding Corp. (NOR) in Focus: Stock Adds 6.6% in Session

Posted Mon Jul 21, 09:11 am ET

by Zacks Equity Research

Noranda Aluminum Holding Corp. (NOR) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 25.76 % in the past one-month time frame.

The company has seen one negative and one positive estimate revisions in the past 30 days, while the Zacks Consensus Estimate has moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Noranda Aluminum currently has a Zacks Rank #4 (Sell) with a positive Earnings ESP.

Some better-ranked stocks in the wider basic materials sector include Alliance Resource Partners LP (ARLP), Hi-Crush Partners LP (HCLP) and U.S. Silica Holdings, Inc. (SLCA). While Alliance Resource Partners and Hi-Crush Partners sport a Zacks Rank #1 (Strong Buy), U.S. Silica Holdings carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Gas Natural (EGAS) Jumps: Stock Rises 6.7%

Posted Mon Jul 21, 09:04 am ET

by Zacks Equity Research

Gas Natural Inc. (EGAS) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $10.31 to $10.70 in the past one-month time frame.

The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Gas Natural currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked companies engaged in utility-gas distribution include The Laclede Group, Inc. (LG), WGL Holdings Inc. (WGL) and AGL Resources Inc. (GAS). While The Laclede Group and WGL Holdings sport a Zacks Rank #1 (Strong Buy), AGL Resources has a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Why STMicroelectronics (STM) Might Be a Diamond in the Rough

Posted Mon Jul 21, 09:00 am ET

by Zacks Equity Research

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.

So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision.

One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is STMicroelectronics NV (STM). This Semi-General stock has actually seen estimates rise over the past month for the current fiscal year by about 19%.  But that is not yet reflected in its price, as the stock lost 4.4% over the same time frame.

You should not be concerned about the price remaining muted going forward. This year’s expected earnings growth over the prior year is 210.1%, which should ultimately translate into price appreciation.

And if this isn’t enough, STM currently carries a Zacks Rank #1 (Strong Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance).

So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider STMicroelectronics. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for STM and that now might be an interesting buying opportunity.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Why The Empire District Electric (EDE) Could Beat Earnings Estimates Again

Posted Mon Jul 21, 08:59 am ET

by Zacks Equity Research

Looking for a stock that might be in a good position to beat earnings at its next report? Consider The Empire District Electric Company (EDE), a firm in the Utilities sector, which could be a great candidate for another beat. 

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, EDE has beaten estimates by at least 15.0% in both cases, suggesting it has a nice short-term history of crushing expectations.

Earnings in Focus

Two quarters ago, EDE expected to post 24 cents per share, while its earnings came in at 35 cents per share, a significant beat. Meanwhile, for the most recent quarter, the company looked to deliver earnings per share of 41 cents, when it actually saw 48 cents per share instead, representing a 17% positive surprise.

Thanks in part to this history, estimates have been moving higher for The Empire District Electric. In fact, the Earnings ESP for EDE is positive, which is a great sign of a coming beat.

After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for EDE, as the firm currently has a Zacks Earnings ESP of 8.70 %, so another beat could be around the corner.

This is particularly true when you consider that EDE has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that EDE could see another beat at its next report, especially if recent trends are any guide.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Full Archive

The content contained in this weblog feature may have been abstracted from a complete Zacks Equity Research report.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.